319 related articles for article (PubMed ID: 33181532)
1. A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma.
Séverin D; Bessaoud F; Meftah N; Du Thanh A; Tretarre B; Guillot B; Makinson A
AIDS; 2021 Mar; 35(3):399-405. PubMed ID: 33181532
[TBL] [Abstract][Full Text] [Related]
2. AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants?
Solivetti FM; Elia F; Latini A; Cota C; Cordiali-Fei P; Di Carlo A
J Exp Clin Cancer Res; 2011 Apr; 30(1):40. PubMed ID: 21489270
[TBL] [Abstract][Full Text] [Related]
3. One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China.
Wu XJ; Pu XM; Kang XJ; Halifu Y; An CX; Zhang DZ; Yakeya B; Mijit J
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1545-52. PubMed ID: 25350316
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes of patients with classic and AIDS-related Kaposi Sarcoma: a single-center real-world experience.
Valcarcel-Valdivia B; Enriquez-Vera D; Piedra LE; Holguín A; De la Cruz Ku G
Clin Exp Med; 2023 Dec; 23(8):5463-5471. PubMed ID: 37940724
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of Kaposi's sarcoma in Hotan region of Xinjiang, China.
Yang HL; He F; Jielili A; Zhang ZR; Cui ZY; Wang JH; Guo HT
Medicine (Baltimore); 2023 Oct; 102(41):e35552. PubMed ID: 37832074
[TBL] [Abstract][Full Text] [Related]
6. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Laboratory Profile of People Living with HIV/AIDS with Oral Kaposi Sarcoma.
Alves CGB; Assis MS; Maciel ADS; da Silva JC; Leite-Ribeiro PM; Lins-Kusterer L; Sarmento VA
AIDS Res Hum Retroviruses; 2021 Nov; 37(11):870-877. PubMed ID: 34538064
[TBL] [Abstract][Full Text] [Related]
8. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
Lajaunie R; Cuzin L; Palich R; Makinson A; Bani-Sadr F; Duvivier C; Arvieux C; Rey D; Poizot-Martin I; Delpierre C; Delobel P; Martin-Blondel G;
HIV Med; 2022 Mar; 23(3):301-306. PubMed ID: 34668293
[TBL] [Abstract][Full Text] [Related]
9. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
[TBL] [Abstract][Full Text] [Related]
10. Fatal pulmonary Kaposi sarcoma in an HIV seronegative AIDS patient.
Zhang H; Wang HL; Zhong DR; Liu Y; Li NN; Zhang W; Xiao Y; Li TS
Clin Respir J; 2017 Nov; 11(6):1040-1044. PubMed ID: 26861193
[TBL] [Abstract][Full Text] [Related]
11. AIDS-related gastrointestinal kaposi sarcoma in Korea: a case report and review of the literature.
Chung CY; Park SW; Myung E; Cho DK; Song YA; Park KJ; Jang HC; Joo YE
Korean J Gastroenterol; 2012 Sep; 60(3):166-71. PubMed ID: 23018538
[TBL] [Abstract][Full Text] [Related]
12. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
[TBL] [Abstract][Full Text] [Related]
13. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
Daly ML; Fogo A; McDonald C; Morris-Jones R
Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
[TBL] [Abstract][Full Text] [Related]
14. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
15. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
17. Variable clinical presentations of Classic Kaposi Sarcoma in Turkish patients.
Altunay I; Kucukunal A; Demirci GT; Ates B
J Dermatol Case Rep; 2012 Mar; 6(1):8-13. PubMed ID: 22514583
[TBL] [Abstract][Full Text] [Related]
18. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
Shiels MS; Pfeiffer RM; Hall HI; Li J; Goedert JJ; Morton LM; Hartge P; Engels EA
JAMA; 2011 Apr; 305(14):1450-9. PubMed ID: 21486978
[TBL] [Abstract][Full Text] [Related]
19. Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.
Poizot-Martin I; Obry-Roguet V; Duvivier C; Lions C; Huleux T; Jacomet C; Ferry T; Cheret A; Allavena C; Bani-Sadr F; Palich R; Cabié A; Fresard A; Pugliese P; Delobel P; Lamaury I; Hustache-Mathieu L; Brégigeon S; Makinson A; Rey D;
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1065-1073. PubMed ID: 31953902
[TBL] [Abstract][Full Text] [Related]
20. Expression of Programmed Cell Death Proteins in Kaposi Sarcoma and Cutaneous Angiosarcoma.
Gambichler T; Koim S; Wrobel M; Käfferlein HU; Brüning T; Stockfleth E; Becker JC; Lang K
J Immunother; 2020 Jun; 43(5):169-174. PubMed ID: 32224717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
